Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 19, 2010Blood

X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMichael H. AlbertTBTanja BittnerSNShigeaki Nonoyama

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Albert et al. (2010) studied this question.

synapsesocial.com/papers/6aaa60be337e25bc782ab308https://doi.org/10.1182/blood-2009-09-239087
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia2002 · 100 citations
  2. 2Recommendations for a nomenclature system for human gene mutations1998 · 942 citations
  3. 3Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome2008 · 35 citations
  4. 4A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk1988 · 5,027 citations
  5. 5Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation2007 · 245 citations